Transition Bio, Inc.
The only end-to-end condensate drug discovery platform built on molecular insights.
29 employees · est. 2020 · Cambridge, United States
Bindkin Bio is the older company (2018 vs 2020); Transition Bio, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Bindkin Bio | Transition Bio, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2020 |
| Headquarters | ||
| Headquarters | Davis, United States | Cambridge, United States |
| Employees | ||
| Employees | 2 | 29 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | $50.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 2 |
| Services | ||
| Services | Not tracked yet | Drug discovery platform, Molecular level insights, Microfluidics technology, AI-driven chemical optimization |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotech firms, Medical research institutions |
| Taxonomy | ||
| Taxonomy | Binding Kinetics, Real-time, Drug Discovery, High-throughput, Computational Drug-target Predictions, CRO (Contract Research Organization), NCEs (New Chemical Entities), Native Protein, Medicine | Condensate Drug Discovery, Molecular Insights, Biomolecular Condensates, Condensomics Platform, Biophysics-Driven Drug Development, Artificial Intelligence In Drug Discovery, Droplet Microfluidics, Cellular Platforms, Condensate Characterization, Proprietary Data Sets, Target Discovery, Target Validation, Drug Design, Diagnostics, Hypothesis-Free Drug Development |
| Website | ||
| Website | bindkinbio.com | transitionbio.com |
About Bindkin Bio
Bindkin Bio is a biotechnology startup founded in 2018 and headquartered in the United States. The company specializes in providing high-throughput, real-time binding kinetics data for various drug discovery purposes. Its slogan "Binding Kinetics in Real Time" emphasizes its core competency. Bindkin...
About Transition Bio, Inc.
Transition Bio, Inc., founded in 2020, is a cutting-edge player in the Biotechnology and Health Care sectors, headquartered in the United States. The company is pioneering the only end-to-end condensate drug discovery platform, branded as Condensomics, that leverages advanced biophysics and artifici...
We will tell you when either one moves
BounceWatch watches Bindkin Bio and Transition Bio, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bindkin Bio and Transition Bio, Inc. — by email.
Frequently Asked Questions
Compare Bindkin Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Bindkin Bio on 14 Sep 2024, and Transition Bio, Inc. on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.